Plasma nesfatin-1 level may be associated with disease severity in patients with panic disorder

Klinik Psikofarmakoloji Bulteni

Volumn 20, Issue 4, 2010, Pages 288-292

  Bez, Yasin ^a   Ari, Mustafa ^b   Ozturk, Oktay Hasan ^b   Oktar, Suleyman ^b   Can, Yesim ^b   Sogut, Sadik ^b  

^a DICLE UNIVERSITY   (Turkey)

^b MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Anxiety; Food intake; Nesfatin 1; Panic disorder; Satiety; Starvation

Indexed keywords

NESFATIN 1; PEPTIDE HORMONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MALE; OUTPATIENT DEPARTMENT; PANIC; PROTEIN BLOOD LEVEL;

EID: 79251486998     PISSN: 10177833     EISSN: 13029657     Source Type: Journal    
DOI: 10.1080/10177833.2010.11790674     Document Type: Article

References (32)

1. Oh I, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, Tsuchiya T, Monden T, Horiguchi K, Yamada M, Mori M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006; 443: 709-712.
2. Brailoiu GC, Dun SL, Brailoiu E, Inan S, Yang J, Chang JK, Dun NJ. Nesfatin-1: distribution and interaction with a g 497 protein-coupled receptor in the rat brain. Endocrinology 2007; 148: 5088-5094. (Pubitemid 47481535)
3. Sakai Y, Kumano H, Nishikawa M, Sakano Y, Kaiya H, Imabayashi E, Ohnishi T, Matsuda H, Yasuda A, Sato A, Diksic M, Kuboki T. Cerebral glucose metabolism associated with a fear network in panic disorder. Neuroreport 2005; 16: 927-931. (Pubitemid 40904741)
4. Erlanson-Albertsson C. How palatable food disrupts appetite regulation. Basic Clin Pharmacol Toxicol 2005; 97: 61-73. (Pubitemid 41021104)
5. Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K. Ghrelin an endogenous growth hormone secretagogue is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001; 50: 227-232.
6. Rao TL, Kokare DM, Sarkar S, Khisti RT, Chopde CT, Subhedar N. GABAergic agents prevent alpha-melanocyte stimulating hormone induced anxiety and anorexia in rats. Pharmacol Biochem Behav 2003; 76: 417-423. (Pubitemid 37487897)
7. Rotzinger S, Lovejoy DA, Tan LA. Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides 2010; 31: 736-756.
8. Merali Z, Cayer C, Kent P, Anisman H. Nesfatin-1 increases anxiety- and fear-related behaviors in the rat. Psychopharmacology 2008; 201: 115-123.
9. Bandelow B, Hajak G, Holrichter S, Kunert H, J, Rüther E. Assessing efficacy of treatments for panic disorder and agoraphobia-I: Methodological problems. Int Clin Psychopharmcol 1995; 10: 83-93.
10. Tsuchiya T, Shimizu H, Yamada M, Osaki A, Oh-I S, Ariyama Y, Takahashi H, Okada S, Hashimoto K, Satoh T, Kojima M, Mori M. Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin Endocrinol (Oxf) 2010 Jun 9 [Epub ahead of print].
11. Aydin S, Dag E, Ozkan Y, Erman F, Dagli AF, Kilic N, Sahin I, Karatas F, Yoldas T, Barim O, Kendir Y. Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders. Mol Cell Biochem 2009; 328: 49-56.
12. Ramanjaneya M, Chen J, Brown JE, Tripathi G, Hallschmid M, Patel S, Kern W, Hillhouse EW, Lehnert H, Tan BK, Randeva HS. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 2010; 151: 3169-3180.
13. Akana SF, Strack AM, Hanson ES, Dallman MF. Regulation of activity in the hypothalamic-pituitary-adrenal axis is integral to a larger hypothalamic system that determines caloric flow. Endocrinology 1994; 135: 1125-1134.
14. Dallman MF, Akana SF, Strack AM, Hanson S, Sebastian RJ. The neural network that regulates energy balance is responsive to glucocorticoids and insulin and also regulates HPA axis responsivity at sites proximal to CRF neurons. Ann NY Acad Sci 1995; 771: 730-742.
15. Merali Z, McIntosh J, Kent P, Michaud D, Anisman H. Aversive and appetitive events evoke the release of corticotropin releasing hormone and bombesin-like peptides at the central nucleus of the amygdala. J Neurosci 1998; 18: 4758-4766.
16. Pecoraro N, Reyes F, Gomez F, Bhargava A, Dallman MF. Chronic stress promotes palatable feeding which reduces signs of stress: feedforward and feedback effects of chronic stress. Endocrinology 2004; 145: 3754-3762.
17. Valles A, Marti O, Garcia A, Armario A. Single exposure to stressors causes long-lasting stress-dependent reduction of food intake in rats. Am J Physiol 2000; 279: R1138-R1144.
18. Tamashiro KL, Hegeman MA, Nguyen MM, Melhorn SJ, Ma LY, Woods SC, Sakai RR. Dynamic body weight and body composition changes in response to subordination stress. Physiol Behav 2007; 91: 440-448.
19. Karbonits M, Trainer PJ, Nelson ML, Howse I, Kopelman PG, Besser GM, Grossman AB, Svec F. Differential stimulation of cortisol and dehydroepiandrosterone levels by food in obese and normal subjects: relation to body fat distribution. Clin Endocrinol 1996; 45: 699-706.
20. Piazza PV, Le Moal M. Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res Rev 1997; 25: 359-372.
21. Koob GF, Heinrichs SC. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res 1999; 848: 141-152.
22. Ueta Y, Ozaki Y, Saito J, Onaka T. Involvement of novel feeding-related peptides in neuroendocrine response to stress. Exp Biol Med 2003; 228: 1168-1174.
23. Ahima RS, Flier JS. Leptin. Annu Rev Physiol 2000; 62: 413-437.
24. Spinazzi R, Andreis PG, Rossi GP, Nussdorfer GG. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol Rev 2006; 58: 46-57.
25. Emul HM, Serteser M, Kurt E, Ozbulut O, Guler O, Gecici O. Ghrelin and leptin levels in patients with obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1270-1274. (Pubitemid 47081315)
26. Liu J, Garza JC, Truong HV, Henschel J, Zhang W, Lu XY. The melanocortinergic pathway is rapidly recruited by emotional stress and contributes to stress-induced anorexia and anxiety-like behavior. Endocrinology 2007; 148: 5531-5540.
27. Tannenbaum BM, Brindley DN, Tannenbaum GS, Dallman MF, McArthur MD, Meaney MJ. High-fat feeding alters both basal and stress-induced hypothalamic-pituitary-adrenal activity in the rat. Am J Physiol 1997; 273: E1168-E1177.
28. Pirildar S, Bayraktar B, Berdeli A, Kucuk A, Alkin T, Kose T. Progesterone receptor gene polymorphism in panic disorder: Associations with agoraphobia and respiratory subtype of panic disorder. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2010; 20: 153-159.
29. Pan W, Hsuchou H, Kastin AJ. Nesfatin-1 crosses the blood-brain barrier without saturation. Peptides 2007; 28: 2223-2228.
30. Price TO, Samson WK, Niehoff ML, Banks WA. Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1. Peptides 2007; 28: 2372-2381.
31. Price CJ, Samson WK, Ferguson AV. Nesfatin-1 inhibits NPY neurons in the arcuate nucleus. Brain Res 2008; 1230: 99-106.
32. Goebel M, Stengel A, Wang L, Taché Y. Restraint stress activates nesfatin-1-immunoreactive brain nuclei in rats. Brain Res 2009; 1300: 114-124.